Mind Medicine Stock Analysis
| MNMD Stock | USD 8.26 0.15 1.85% |
Mind Medicine is overvalued with Real Value of 7.3 and Target Price of 8.0. The main objective of Mind Medicine stock analysis is to determine its intrinsic value, which is an estimate of what Mind Medicine is worth, separate from its market price. There are two main types of Mind Medicine's stock analysis: fundamental analysis and technical analysis.
The Mind Medicine stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mind Medicine's ongoing operational relationships across important fundamental and technical indicators.
Mind |
Mind Stock Analysis Notes
About 68.0% of the company shares are owned by institutional investors. The book value of Mind Medicine was now reported as 3.21. The company recorded a loss per share of 1.71. Mind Medicine last dividend was issued on the 27th of February 2020. The entity had 1:15 split on the 29th of August 2022. Mind Medicine Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. Mind Medicine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. To find out more about Mind Medicine contact Robert Barrow at 212-220-6633 or learn more at https://www.mindmed.co.Mind Medicine Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mind Medicine's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mind Medicine or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Mind Medicine appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (95.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mind Medicine currently holds about 105.74 M in cash with (64.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71. | |
| Mind Medicine has a frail financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: MindMeds SWOT analysis psychedelic stocks potential in anxiety treatment |
Mind Medicine Upcoming and Recent Events
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Mind Largest EPS Surprises
Earnings surprises can significantly impact Mind Medicine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-13 | 2024-06-30 | -0.33 | -0.26 | 0.07 | 21 | ||
2023-05-04 | 2023-03-31 | -0.42 | -0.52 | -0.1 | 23 | ||
2024-02-28 | 2023-12-31 | -0.46 | -0.59 | -0.13 | 28 |
Mind Medicine Environmental, Social, and Governance (ESG) Scores
Mind Medicine's ESG score is a quantitative measure that evaluates Mind Medicine's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Mind Medicine's operations that may have significant financial implications and affect Mind Medicine's stock price as well as guide investors towards more socially responsible investments.
Mind Medicine Thematic Classifications
In addition to having Mind Medicine stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services |
Mind Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Artal Group S A | 2024-06-30 | 1 M | Woodline Partners Lp | 2024-06-30 | 1 M | Awm Investment Company Inc | 2024-09-30 | 853 K | Ally Bridge Group (ny) Llc | 2024-09-30 | 788.5 K | Northern Trust Corp | 2024-09-30 | 608.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 602.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 316 K | Two Sigma Investments Llc | 2024-09-30 | 279 K | Bank Of New York Mellon Corp | 2024-06-30 | 246.2 K | Commodore Capital Lp | 2024-09-30 | 8 M | Deep Track Capital, Lp | 2024-09-30 | 7.1 M |
Mind Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 605.72 M.Mind Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.92) | (0.97) | |
| Return On Capital Employed | (1.02) | (1.07) | |
| Return On Assets | (0.77) | (0.81) | |
| Return On Equity | (1.23) | (1.29) |
Management Efficiency
Mind Medicine has return on total asset (ROA) of (0.2538) % which means that it has lost $0.2538 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5461) %, meaning that it created substantial loss on money invested by shareholders. Mind Medicine's management efficiency ratios could be used to measure how well Mind Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -0.97. In addition to that, Return On Capital Employed is expected to decline to -1.07. At present, Mind Medicine's Tangible Asset Value is projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.11, whereas Net Tangible Assets are forecasted to decline to about 91.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.00 | 1.90 | |
| Net Current Asset Value | 171.4 K | 147.7 K | |
| Tangible Asset Value | 3.2 M | 3.3 M | |
| Tangible Book Value Per Share | 1.47 | 1.40 | |
| Enterprise Value Over EBITDA | (0.62) | (0.65) | |
| Price Book Value Ratio | 1.83 | 1.82 | |
| Enterprise Value Multiple | (0.62) | (0.65) | |
| Price Fair Value | 1.83 | 1.82 | |
| Enterprise Value | 57.7 M | 47.9 M |
Mind Medicine has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 2.332 | Return On Assets (0.25) | Return On Equity (0.55) |
Technical Drivers
As of the 29th of November, Mind Medicine secures the Mean Deviation of 3.63, downside deviation of 3.98, and Risk Adjusted Performance of 0.0953. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mind Medicine, as well as the relationship between them. Please verify Mind Medicine treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Mind Medicine is priced some-what accurately, providing market reflects its recent price of 8.26 per share. Given that Mind Medicine has jensen alpha of 0.1663, we recommend you to check Mind Medicine's last-minute market performance to make sure the company can sustain itself at a future point.Mind Medicine Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mind Medicine middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mind Medicine. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Mind Medicine Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mind Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mind Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mind Medicine insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mind Medicine Outstanding Bonds
Mind Medicine issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mind Medicine uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mind bonds can be classified according to their maturity, which is the date when Mind Medicine has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Mind Medicine Predictive Daily Indicators
Mind Medicine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mind Medicine stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Mind Medicine Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 22nd of October 2024 Other Reports | ViewVerify | |
| 17th of October 2024 Other Reports | ViewVerify | |
F4 | 25th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 26th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 22nd of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Mind Medicine Forecast Models
Mind Medicine's time-series forecasting models are one of many Mind Medicine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mind Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Mind Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Mind Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mind shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mind Medicine. By using and applying Mind Stock analysis, traders can create a robust methodology for identifying Mind entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Current Mind Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mind analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mind analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 8.0 | Strong Buy | 4 | Odds |
Most Mind analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mind stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mind Medicine, talking to its executives and customers, or listening to Mind conference calls.
Mind Stock Analysis Indicators
Mind Medicine stock analysis indicators help investors evaluate how Mind Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mind Medicine shares will generate the highest return on investment. By understating and applying Mind Medicine stock analysis, traders can identify Mind Medicine position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 142.1 M | |
| Long Term Debt | 14.1 M | |
| Common Stock Shares Outstanding | 39.2 M | |
| Total Stockholder Equity | 78.1 M | |
| Cash And Short Term Investments | 99.7 M | |
| Cash | 99.7 M | |
| Accounts Payable | 4.1 M | |
| Net Debt | -85.6 M | |
| 50 Day M A | 6.5467 | |
| Total Current Liabilities | 32.2 M | |
| Other Operating Expenses | 93.9 M | |
| Non Current Assets Total | 20.7 M | |
| Non Currrent Assets Other | 224 K | |
| Stock Based Compensation | 15.5 M |
Complementary Tools for Mind Stock analysis
When running Mind Medicine's price analysis, check to measure Mind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mind Medicine is operating at the current time. Most of Mind Medicine's value examination focuses on studying past and present price action to predict the probability of Mind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mind Medicine's price. Additionally, you may evaluate how the addition of Mind Medicine to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |